← Browse by Condition
Medical Condition
atopic dermatitis eczema
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 4, Phase 2
NCT06004986 Phase 4
Recruiting
DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema
Enrollment
216 pts
Location
Netherlands
Sponsor
Academisch Medisch Centrum - U...
NCT07037901 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Enrollment
220 pts
Location
United States, Canad...
Sponsor
Inmagene LLC